Skip to main content

A phase 3, multicentre, randomised, double-blind, vehicle-controlled, parallel-group study to evaluate, the efficacy and safety of tribanulib 10 mg, ointment applied to a treatment, field larger than 25 cm and up to 10 cm in adult patients with actinic keratosis.

Open
  • Protocol code: M-14867-33
  • EudraCT code: No aplica
  • Research group: Biomedical Research in Melanoma
  • Service: Dermatologia
  • Principal investigator:  Ferrándiz Pulido, Carla
  • Pathology: Tumors
  • Phase: Fase III
  • Status: Recruiting volunteers